Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The FDA STAR pilot program aims to shorten the time from a complete supplemental new drug application submission to the action date. Entry into the STAR program qualifies plozasiran for a 6-month Priority Review, compared to a 10-month standard review.
FDA STAR pilot program aims to shorten the time from complete supplement submission to the action date to allow earlier patient access to therapies that address an unmet medical need PASADENA, Calif.--()--October 07, 2026-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the United States Food and D